Vesteck develops a proprietary endosuturing platform for endograft fixation in endovascular aortic repair (EVAR) and thoracic endovascular aortic repair (TEVAR) procedures. This technology addresses the challenge of secure and reliable fixation of endografts, enhancing procedural outcomes and patient safety.
Funding
$25.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Endovascular aortic repair (EVAR) and thoracic endovascular aortic repair (TEVAR) procedures require secure and reliable fixation of endografts to prevent migration and subsequent complications. Current methods may not always provide adequate long-term fixation, potentially leading to re-intervention.
Solution
Vesteck has developed the Suture-Tight™ endosuturing platform designed to enhance endograft fixation during EVAR and TEVAR procedures. This proprietary technology aims to improve the security and reliability of endograft placement, potentially reducing the risk of migration and improving long-term patient outcomes. The platform is intended to provide a more robust and consistent fixation method compared to existing techniques.
Target Audience
The primary target audience includes vascular surgeons and interventional radiologists performing EVAR and TEVAR procedures.
Features
- Proprietary endosuturing platform for EVAR and TEVAR procedures
- Designed for secure and reliable endograft fixation
- Aims to reduce the risk of endograft migration